TraumaNCT02011412
Intermountain Risk Score and Trauma
An observational study of Trauma and Injury, run by Intermountain Health Care, Inc. at 1 site in United States.
Trial summary
The investigators hypothesize that a risk score composed of age, sex, and the components of commonly ordered laboratory panels will be predictive of mortality in trauma patients, and will help improve clinicians' ability to make more accurate mortality predictions at the time of admission. Read more about this study
- Who is it for?
- Ages 18 years and older
- How many people
- 400 participants
- Where
- 1 siteUnited States
- Study dates
- Oct 2013to Dec 2015
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Individuals who suffer from a traumatic injury and present to the Emergency Department as a Trauma Activation
Who may be able to join
- Patient presents to Intermountain Medical Center as a Level I or Level II trauma activation.
- Age ≥18
Who cannot join
- Patients who are not admitted to the hospital
- Patients who expire in the Emergency Department
- Patients who are discharged to home from the Emergency Department
- Patients who do not have a complete blood count and basic metabolic profile drawn in the Emergency Department as part of routine clinical care.
- Patients who enter the hospital as "trauma consults." These patients have traumatic injuries, and are often admitted to the trauma service, but the severity of their trauma is not thought to warrant trauma team activation.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Intermountain Risk Score's Association With Mortality Prediction in Trauma Patients
The investigators hypothesize that a risk score composed of age, sex, and the components of commonly ordered laboratory panels will be predictive of mortality in trauma patients, and will help improve clinicians' ability to make more accurate mortality predictions at the time of admission.
- Keywords
- Trauma, Scoring Systems, Intermountain Risk Score
- Medical subject headings
- Wounds and Injuries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Intermountain Risk Score known | Not described | |
| Intermountain Risk Score Unknown | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
all cause mortality
To determine whether the Intermountain Risk Score accurately predicts 30 day mortality and one year mortality in trauma patients.
Measured: 30 days
all cause mortality
measure the ability of the Intermountain Risk Score to predict all cause mortality at one year after the traumatic event
Measured: 1 year
Secondary outcomes (2)
experienced clinicians mortality prediction
compare the IMRS to experienced clinicians' ability to predict mortality at 30 days
Measured: 30 days
Experienced Clinicians' mortality prediction
compare the IMRS to experienced clinicians' ability to predict mortality at 1 year
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Dec 2013 (estimated)
- Study startOct 2013
- Primary completionDec 2015
- Study completionDec 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for TraumaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 400 participants (actual)
Sponsor and investigators
- Lead sponsor
- Intermountain Health Care, Inc.
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Sarah Majercik, Intermountain Health Care, Inc.
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02011412
- Sponsor's protocol ID
- 1024710
- Status last verified
- Feb 2016
- First submitted
- 6 Nov 2013
- Last updated
- 24 Feb 2016
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 Feb 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Intermountain Risk Score's Association With Mortality Prediction in Trauma Patients
- ClinicalTrials.gov ID
- NCT02011412
- Acronym / sponsor ID
- 1024710
- Keywords
- Trauma, Scoring Systems, Intermountain Risk Score
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 400 participants (actual)
- Lead sponsor
- Intermountain Health Care, Inc.University, hospital or other
- Study start
- Oct 2013
- Primary completion
- Dec 2015 (actual)
- Study completion
- Dec 2015 (actual)
- First posted
- 13 Dec 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The investigators hypothesize that a risk score composed of age, sex, and the components of commonly ordered laboratory panels will be predictive of mortality in trauma patients, and will help improve clinicians' ability to make more accurate mortality predictions at the time of admission.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intermountain Risk Score known | – | – |
| Intermountain Risk Score Unknown | – | – |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Individuals who suffer from a traumatic injury and present to the Emergency Department as a Trauma Activation
Key inclusion criteria (2 listed)
- Patient presents to Intermountain Medical Center as a Level I or Level II trauma activation.
- Age ≥18
Key exclusion criteria (5 listed)
- Patients who are not admitted to the hospital
- Patients who do not have a complete blood count and basic metabolic profile drawn in the Emergency Department as part of routine clinical care.
- Patients who enter the hospital as "trauma consults." These patients have traumatic injuries, and are often admitted to the trauma service, but the severity of their trauma is not thought to warrant trauma team activation.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
all cause mortality
Time frame: 30 days
To determine whether the Intermountain Risk Score accurately predicts 30 day mortality and one year mortality in trauma patients.
all cause mortality
Time frame: 1 year
measure the ability of the Intermountain Risk Score to predict all cause mortality at one year after the traumatic event
2 secondary outcomes
experienced clinicians mortality prediction
Time frame: 30 days
Experienced Clinicians' mortality prediction
Time frame: 1 year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Feb 2016.
Related trials for Trauma
Not yet recruitingPhase 1
Bioengineered Penile Tissue Constructs for Irreversibly Damaged Penile Corpora
Urologic Diseases, Male Urogenital Diseases
RecruitingPhase 1
NG004 in Incomplete Spinal Cord Injury Patients
Acute Spinal Cord Injury (SCI), Spinal Cord Diseases
Active, not recruiting
Group-based Stabilization and Skill Training for Patients With Lasting Posttraumatic Reactions in Mental Health Care
Stress Disorders, Post-Traumatic, Mental Disorders
Enrolling by invitation
PATH to Reducing Burnout Among Peers Who Deliver Overdose Prevention Services (R33 Phase Clinical Trial)
Burnout, Secondary Trauma
Recruiting
Corneal Trauma Diagnostic Study
Ocular Trauma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Trauma and Injury, run by Intermountain Health Care, Inc. at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 24 Feb 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
all cause mortality (time frame: 30 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Feb 2016; AzTrials last refreshed its copy on 27 Oct 2026.